Literature DB >> 15764114

Clinical research, comparison of the subjective visual function in patients with epiphora and patients with second-eye cataract.

Namir Kafil-Hussain1, Ramona Khooshebah.   

Abstract

PURPOSE: To assess the subjective visual disability of patients with epiphora and to compare the results with that of patients waiting for second eye cataract surgery.
DESIGN: A prospective, randomised, questionnaire-based study.
METHODS: Forty-six patients with epiphora listed for dacryocystorhinostomy and 50 patients having second eye cataract extraction were enrolled. A questionnaire focusing on functional visual disability in daily life and based on VF-14 was completed for each participant.
RESULTS: Eighty-six percent of patients with epiphora and 41% of second-eye cataracts had difficulty reading small print (P < 0.05). The extent of such difficulty was moderate to great in 48% of epiphora and only 26% of cataract patients .A substantial percentage of epiphora patients and second eye cataract also reported difficulty with other tasks, such as doing fine work (78.9% vs. 42%) (P < 0.05), watching television (63.1% vs. 19%) (P < 0.05), seeing steps or stairs (43.4% vs. 10%) (P < 0.05), or reading signs (39.1% vs. 4%) (P < 0.05), respectively.
CONCLUSIONS: There is widespread recognition of the effect of cataract on visual function. This has resulted in substantial government funding to improve access to cataract surgery. In comparison, epiphora is rarely considered as a significant cause of visual disability. This study suggests that patients with epiphora suffer the same if not more of a visual handicap than patients awaiting second eye cataract surgery.

Entities:  

Mesh:

Year:  2005        PMID: 15764114     DOI: 10.1080/01676830590897155

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  7 in total

1.  Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.

Authors:  Z Sipkova; O Vonica; O Olurin; E E Obi; A R Pearson
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

2.  Patient-reported benefit from oculoplastic surgery.

Authors:  H B Smith; S B Jyothi; O A R Mahroo; P N Shams; M Sira; S Dey; T Adewoyin; V T F Cheung; C A Jones
Journal:  Eye (Lond)       Date:  2012-09-14       Impact factor: 3.775

Review 3.  Lacrimal gland botulinum toxin injection for epiphora management.

Authors:  Johnathan Jeffers; Katherine Lucarelli; Sruti Akella; Pete Setabutr; Ted H Wojno; Vinay Aakalu
Journal:  Orbit       Date:  2021-08-15

4.  Current practice trends for lacrimal gland neurotoxin in the management of epiphora-a BOPSS survey.

Authors:  Micheal A O'Rourke; Paul S Cannon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-18       Impact factor: 3.117

5.  Impact of epiphora on vision-related quality of life.

Authors:  Jae-Ho Shin; Yoon-Duck Kim; Kyung In Woo
Journal:  BMC Ophthalmol       Date:  2015-01-21       Impact factor: 2.209

6.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03

7.  The watery eye quality of life (WEQOL) questionnaire: a patient-reported outcome measure for surgically amenable epiphora.

Authors:  Christopher B Schulz; Paul Rainsbury; Jeremy J Hoffman; Laura Ah-Kye; Elizabeth Yang; Raman Malhotra; Simon Rogers; Peter Fayers; Tessa Fayers
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 4.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.